Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Early cardiotoxicity and survival in pediatric Acute Myeloid Leukemia: The mediating roles of relapse and salvage chemotherapy intensity

Blood (2025) 146 (Supplement 1): 5169.

https://doi.org/10.1182/blood-2025-5169

Published: 2025

Journal Articles

Initiation of ACE inhibitors or beta-blockers during frontline therapy for pediatric Acute Myeloid Leukemia and the impacts on cardiotoxicity incidence and survival outcomes: A target trial emulation

Blood (2025) 146 (Supplement 1): 876.

https://doi.org/10.1182/blood-2025-876

Published: 2025

Journal Articles

Influence of air quality on clinical acuity at presentation in pediatric patients with newly diagnosed Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 2848.

https://doi.org/10.1182/blood-2025-2848

Published: 2025

Journal Articles

Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: A report from the DFCI ALL 16-001 Trial

Blood (2025) 146 (Supplement 1): 710.

https://doi.org/10.1182/blood-2025-710

Published: 2025

Journal Articles

Inadequate social support and household material hardship among children with pediatric acute lymphoblastic leukemia: A report from the Children's oncology group Trial AALL1731

Blood (2025) 146 (Supplement 1): 132.

https://doi.org/10.1182/blood-2025-132

Published: 2025

Journal Articles

The feasibility of collecting social determinants of health in the national multi-center GRASP sickle cell gene therapy trial

Colleen Kelly, Morgan Paul, Wendy London, Rahela Aziz-Bose, Puja Umaretiya, Erica Esrick, Victoria Coleman-Cowger, Gary Schiller, Mehrdad Abedi, Joseph Antin, Mary Horowitz, Neena Kapoor, Edmund Waller, Sonali Chaudhury, Mary Eapen, Mark Walters, David Williams, Kira Bona

Blood (2025) 146 (Supplement 1): 6224.

https://doi.org/10.1182/blood-2025-6224

Published: 2025

Journal Articles

Parental perspectives on financial distress during treatment for childhood acute lymphoblastic leukemia: A qualitative report from Children's oncology group (COG) study ACCL20N1CD

Joanna Robles, Sheila Santacroce, Melissa Beauchemin, Yudy Muñeton-Castaño, Olivia Ponce, Lingyun Ji, Subhash Ramakrishnan, Kira Bona, Sarah Vargas, Crystal De Los Santos, Beth Fisher, Sarah Alexander, Lillian Sung, Susan Parsons

Blood (2025) 146 (Supplement 1): 2623.

https://doi.org/10.1182/blood-2025-2623

Published: 2025

Journal Articles

Optimization of induction chemotherapy in pediatric patients with Acute Myeloid Leukemia: Real-world evidence to support removal of etoposide from induction 1

Blood (2025) 146 (Supplement 1): 603.

https://doi.org/10.1182/blood-2025-603

Published: 2025

Journal Articles

Real-world post-relapse survival outcomes in children with Acute Myeloid Leukemia by race and ethnicity

Blood (2025) 146 (Supplement 1): 602.

https://doi.org/10.1182/blood-2025-602

Published: 2025

Journal Articles

Household material hardship as a barrier to accessing sickle cell disease curative therapy

Colleen Kelly, Morgan Paul, McKenzie Griffin, Sunyu Kang, Anna Revette, Rahela Aziz-Bose, Leanne Duhaney, Callie Fry, Puja Umaretiya, Natasha Archer, Kira Bona

Blood (2025) 146 (Supplement 1): 2672.

https://doi.org/10.1182/blood-2025-2672

Published: 2025

Journal Articles

National landscape of real-world pediatric blinatumomab care delivery in the United States: A report from the Children's Oncology Group

Blood (2025) 146 (Supplement 1): 1077.

https://doi.org/10.1182/blood-2025-1077

Published: 2025

Journal Articles

Feasibility of collecting social determinants of health data in the frontline pediatric acute lymphoblastic leukemia (ALL) trial AALL1731: A report from the Children's oncology group

Blood (2025) 146 (Supplement 1): 2742.

https://doi.org/10.1182/blood-2025-2742

Published: 2025

Journal Articles

Household Material Hardship and Inpatient Days in Dana-Farber Cancer Institute (DFCI) Acute Lymphoblastic Leukemia (ALL) Consortium Trial 16-001

Blood (2024) 144 (Supplement 1): 3649.

https://doi.org/10.1182/blood-2024-199274

Published: 2024

Journal Articles

Public Insurance As a Proxy Measure of Household Poverty-Exposures Among Children with Hematologic Malignancies

Rahela Aziz-Bose, Morgan A. Paul, Yael Flamand, Colleen A. Kelly, Leanne Duhaney, Puja J. Umaretiya, Lucille Lokko, McKenzie Griffin, Alexandria Hawkins, Peter D. Cole, Lisa M. Gennarini, Justine M. Kahn, Kara M. Kelly, Victoria B. Koch, Bruno Michon, Thai Hoa Tran, Jennifer J.G. Welch, Lewis B. Silverman, Kira Bona

Blood (2024) 144 (Supplement 1): 3750.

https://doi.org/10.1182/blood-2024-205672

Published: 2024

Journal Articles

Food Insecurity and Cardiovascular Risk Among Survivors of Pediatric Hematologic Malignancies

Rahela Aziz-Bose, Lucille Lokko, Morgan A. Paul, Colleen A. Kelly, Leanne Duhaney, Puja J. Umaretiya, Fang Fang Zhang, Lisa B. Kenney, Kira Bona

Blood (2024) 144 (Supplement 1): 5130.

https://doi.org/10.1182/blood-2024-199220

Published: 2024

Journal Articles

Real-World Generalizability of Clinical Trial Cytomolecular Features By Race and Ethnicity in Pediatric Acute Myeloid Leukemia (AML)

Blood (2024) 144 (Supplement 1): 531.

https://doi.org/10.1182/blood-2024-198385

Published: 2024

Journal Articles

Pediatric RISE: Development of a Poverty-Targeted Cash Support Intervention for Pediatric Cancer

Colleen A. Kelly, Morgan A. Paul, Jennifer Kellett, Sunyu Kang, Anna Revette, Rahela Aziz-Bose, Leanne Duhaney, Puja J. Umaretiya, Erika Hanson, Kira Bona

Blood (2024) 144 (Supplement 1): 402.

https://doi.org/10.1182/blood-2024-210754

Published: 2024

Journal Articles

Survival Disparities By Frontline Clinical Trial Enrollment Status for Treatment of Pediatric Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 2430.

https://doi.org/10.1182/blood-2023-189240

Published: 2023

Journal Articles

Establishing a Sociodemographic Data Banking Study in Patients with Hematologic Disorders - a Feasibility Assessment

Morohuntodun O. Oni, Alexandria Hawkins, Emily Stein, Steven G. Dubois, Katie A. Greenzang, Rahela Aziz-Bose, Christine Duncan, Allison F. O'Neill, Andrew E. Place, Puja J. Umaretiya, Natasha Archer, Kira Bona

Blood (2023) 142 (Supplement 1): 2384.

https://doi.org/10.1182/blood-2023-187703

Published: 2023

Journal Articles

Racial and Ethnic Differences in Acuity and Cumulative Frontline Organ Toxicity at the Time of Relapse in Pediatric Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 387.

https://doi.org/10.1182/blood-2023-180713

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Early cardiotoxicity and survival in pediatric Acute Myeloid Leukemia: The mediating roles of relapse and salvage chemotherapy intensity

Initiation of ACE inhibitors or beta-blockers during frontline therapy for pediatric Acute Myeloid Leukemia and the impacts on cardiotoxicity incidence and survival outcomes: A target trial emulation

Influence of air quality on clinical acuity at presentation in pediatric patients with newly diagnosed Acute Myeloid Leukemia

Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: A report from the DFCI ALL 16-001 Trial

Inadequate social support and household material hardship among children with pediatric acute lymphoblastic leukemia: A report from the Children's oncology group Trial AALL1731

The feasibility of collecting social determinants of health in the national multi-center GRASP sickle cell gene therapy trial

Parental perspectives on financial distress during treatment for childhood acute lymphoblastic leukemia: A qualitative report from Children's oncology group (COG) study ACCL20N1CD

Optimization of induction chemotherapy in pediatric patients with Acute Myeloid Leukemia: Real-world evidence to support removal of etoposide from induction 1

Real-world post-relapse survival outcomes in children with Acute Myeloid Leukemia by race and ethnicity

Household material hardship as a barrier to accessing sickle cell disease curative therapy

National landscape of real-world pediatric blinatumomab care delivery in the United States: A report from the Children's Oncology Group

Feasibility of collecting social determinants of health data in the frontline pediatric acute lymphoblastic leukemia (ALL) trial AALL1731: A report from the Children's oncology group

Household Material Hardship and Inpatient Days in Dana-Farber Cancer Institute (DFCI) Acute Lymphoblastic Leukemia (ALL) Consortium Trial 16-001

Public Insurance As a Proxy Measure of Household Poverty-Exposures Among Children with Hematologic Malignancies

Food Insecurity and Cardiovascular Risk Among Survivors of Pediatric Hematologic Malignancies

Real-World Generalizability of Clinical Trial Cytomolecular Features By Race and Ethnicity in Pediatric Acute Myeloid Leukemia (AML)

Pediatric RISE: Development of a Poverty-Targeted Cash Support Intervention for Pediatric Cancer

Survival Disparities By Frontline Clinical Trial Enrollment Status for Treatment of Pediatric Acute Myeloid Leukemia

Establishing a Sociodemographic Data Banking Study in Patients with Hematologic Disorders - a Feasibility Assessment

Racial and Ethnic Differences in Acuity and Cumulative Frontline Organ Toxicity at the Time of Relapse in Pediatric Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only